1. Methodology and Scope

This thematic report compiles primary-source citations on 25+ active US specialty insurance, wholesale broker, MGA, MGU, and fronting carrier private-equity platforms during 2024 to 2026. The compilation draws on AM Best September 2025 market segment reports, the WSIA Surplus Lines Stamping Office composite (15 US states), Conning 2025 MGA Strategic Study (“Built for What’s Next”), Sica Fletcher H1 2025 broker M&A database, William Blair’s 2025 Insurance Distribution research, MarshBerry Insurance Agency & Brokerage Compensation Study, Gallagher Re’s fronting carrier composite, NAIC MGA Model Act regulatory texts, SEC EDGAR filings for RYAN, BOW, SKWD, HGTY, ARX, WTW, and direct press releases from Carlyle, Bain Capital, Onex, GTCR, Hellman & Friedman, Genstar, Mubadala, Stone Point Capital, CD&R, and Brown & Brown.

Confidence labels appear after each cell: HIGH where primary sources are dated and named; MEDIUM where one primary source confirms with corroborating secondary; LOW where only secondary trade-press exists; GAP where the brief could not surface a current primary source. The report covers the US market with selective Canadian and Bermudian primary references where the entity domiciles abroad but writes US risk (Trisura, Accredited, Accelerant). Premium figures are direct written premium unless otherwise stated. Multiples are stated as EV / EBITDA or EV / revenue and labeled at each cell. (Confidence: HIGH on methodology framing.)

Scope boundaries. This report intentionally separates four overlapping but structurally distinct categories: (1) specialty and wholesale brokers, which earn commission on placement of E&S and difficult-to-place business between retail brokers and specialty carriers; (2) MGAs (Managing General Agents), which carry underwriting authority delegated by an insurance carrier but typically without retention of risk; (3) MGUs (Managing General Underwriters), which carry meaningfully deeper authority including pricing, binding, claims handling, and in many cases profit-sharing on loss ratio; and (4) fronting carriers, which provide regulatory paper for MGAs and program managers and retain a portion of the underlying risk (hybrid retention model) or cede the majority of risk to reinsurers. The four categories warrant distinct multiple bands because of different operating gearing, different capital intensity, and different cycle sensitivity. (Confidence: HIGH.)

Public-private distinction. The report treats public companies (NYSE: RYAN, NYSE: BOW, NASDAQ: SKWD, NYSE: HGTY, NYSE: ARX, NYSE: MKL, NASDAQ: LMND, NASDAQ: GLRE, NASDAQ: WTW, NYSE: AJG, NYSE: BRO, NYSE: MMC, NYSE: AON, TSX: TSU) as separate comp universes from private sponsor-backed platforms. Public companies must file quarterly with the SEC (or the TSX equivalent) and their financials are auditable. Private sponsor-backed platforms rely on press releases, sponsor portfolio pages, and trade press for verification. The report flags multiple confidence appropriately based on this distinction. (Confidence: HIGH.)

Time window. The report covers calendar years 2024 through 2026 with selected look-back to 2022 and 2023 for foundational sponsor relationships (Carlyle / NSM 2022; Hilb Group / Carlyle 2019; Stone Point / CRC 2023). The look-back is necessary because cycle-end specialty insurance analysis requires multi-year baselines. The report does not forecast beyond December 31, 2026; multiples bands and concentration findings reflect mid-cycle data through June 21, 2026. (Confidence: HIGH.)

What this report does NOT cover. The report is not a comprehensive census of all 850+ NAIC-filed MGAs nor a full directory of every E&S program manager. The report is selective on platforms where (a) a primary-source sponsor or public-market filing exists, (b) the platform has either crossed $50M+ in premium or has cap-table action in 2024-2026, or (c) the platform is a frequently miscategorized data point that needs correction (AmWINS, Clear Blue). For exhaustive platform censuses, sponsors should consult Conning’s MGA Strategic Study and AM Best’s annual program manager directory. (Confidence: HIGH.)

2. Macro Spine: WSIA, AAMGA, Conning, AM Best Market Sizes

The four canonical market sizes for US specialty insurance in 2024 to 2026 are: total US E&S direct written premium of approximately $135 billion in 2024, up 12.3% from 2023 per the AM Best September 2025 market segment report (compared to 17.4% growth in 2023) (AM Best, Sept 2025; Confidence: HIGH); the 15 US surplus lines stamping office composite of $90.3 billion in FY2025, up 7.8% from $83.8 billion in 2024 with policy item counts up 14.1% year on year (WSIA via The Insurer, Jan 30 2026; Confidence: HIGH); Conning’s US MGA premium of $114.1 billion in 2024, up 16% year on year, again outpacing broader P/C growth (Conning via PR Newswire; Confidence: HIGH); and the Gallagher Re composite of fronting carrier GWP of $28 billion in 2024 (+26% year on year), with fronting carriers supporting roughly 20% of total US MGA premium (Gallagher Re via Risk & Insurance; Confidence: HIGH).

Sub-segment composition for 2024 MGA premium per Conning: non-affiliated MGAs (independent of insurance company parents) held 46.6% share, affiliated MGAs (owned by an insurance company) 45.3%, and crop MGAs 8.1% (Carrier Management, July 2025; Confidence: HIGH). H1 2025 stamping office data showed $46.2 billion in premium, up 13.2% year on year, with commercial liability non-professional accounting for 36.6% of the half and commercial property 34.0% (Risk & Insurance; Confidence: HIGH). Texas posted +9.8% premium growth in 2025; Florida posted +1.8% on premium but +11.6% on item counts, the canonical signal of admitted-to-surplus risk migration (Confidence: HIGH).

The Conning 2024 study additionally calculated a 21% five-year CAGR for the broader E&S market through 2023, with premiums surpassing $104 billion at year-end 2023 (Patra via Conning; Confidence: HIGH). Seven consecutive years of double-digit E&S premium growth through 2024 establish the macro tailwind that drives sponsor appetite for specialty broker, MGA, and fronting carrier acquisition. (Confidence: HIGH on cycle thesis.)

The growth deceleration signal. The 12.3% E&S growth in 2024 represents a deceleration from the 17.4% recorded in 2023, the first material slowdown since the post-2017 hard-market cycle began. The deceleration matters for sponsors because (a) it reduces the rate-driven component of MGA premium growth and shifts the underlying driver from rate to exposure migration, (b) it compresses the upper end of growth-adjusted multiple bands for platforms that depended on rate during 2022-2023, and (c) it brings forward the soft-cycle pricing conversation that AM Best formalized in its November 2025 outlook revision from positive to stable. The 13.2% H1 2025 stamping office growth surge appears to contradict the deceleration narrative, but H1 2025 captured the tail of carryover rate from 2024 renewals and may not extend through H2 2025. The full FY2025 stamping office figure of 7.8% growth is the more reliable signal of cycle deceleration. (Confidence: HIGH on the deceleration signal; MEDIUM on the trajectory through end-of-cycle.)

Why MGA growth outpaced P/C in 2024. The 16% MGA growth vs 12.3% E&S growth gap reflects three structural drivers: (a) underwriting talent migration from carriers to MGAs continues, which adds new MGA programs at the rate of 50-80 per year per Conning; (b) capacity providers (fronting carriers, reinsurers, and Lloyd’s syndicates) have expanded MGA capacity to fill admitted-market retreat from cat-exposed property and certain liability lines; and (c) sponsor-backed MGA platforms (NSM under Carlyle, Hilb Specialty, Distinguished under White Mountains) have aggregated regional MGAs into national platforms, which adds same-store growth on top of new-program growth. The 16% / 12.3% growth gap is unlikely to persist at this magnitude through 2026-2027 because as MGA scale increases, growth math gets harder. Sponsors underwriting MGA platforms should price in growth normalization to 10-13% per year by 2027. (Confidence: MEDIUM on growth normalization; HIGH on the directional thesis.)

3. The AmWINS / Dragoneer Correction (Not Stone Point)

Public coverage frequently miscategorizes AmWINS’ sponsor as Stone Point Capital. The actual current cap table is: employee shareholders at roughly 40% (largest single block), Dragoneer Investment Group (largest institutional investor), Genstar Capital, SkyKnight Capital, and Public Sector Pension Investment Board (PSP Investments) which rolled 80% of its position forward. The recapitalization closed on November 15, 2023 for $1.0 billion in equity (Genstar Capital release, Nov 15 2023; Confidence: HIGH).

Stone Point Capital does appear in US specialty insurance, but at the CRC / Truist Insurance Holdings level: Mubadala + Stone Point + CD&R acquired the remaining 80% of Truist Insurance Holdings at $15.5B enterprise value in 2024, with TIH units now comprising CRC Insurance Services + Crump Life Insurance Services + AmRisc (Mubadala Annual Report 2024; Confidence: HIGH). Coverage that places Stone Point at AmWINS conflates the two largest US wholesale broker cap tables and creates a recurring data error in sponsor benchmarking. CT Acquisitions’ position: any thesis that requires AmWINS sponsor identification must reference the Genstar press release of November 15, 2023 as the primary source, not secondary trade press. (Confidence: HIGH.)

Why the miscategorization persists. Stone Point Capital is one of the most active US specialty insurance sponsors and has held positions in numerous insurance brokerage and program manager platforms over the past two decades. AmWINS is the largest US wholesale broker by premium placed. The combination creates a “default association” in trade press that survives even after primary-source contradictions exist. The November 15, 2023 Genstar release names every party in the AmWINS cap table including the rolled PSP position and the 40% employee block, but the release receives less indexing weight than aggregated trade-press summaries that repeat the earlier Stone Point linkage. Sponsors building specialty insurance theses must trace primary sources for cap-table identification rather than rely on aggregated coverage. (Confidence: HIGH on diagnosis.)

The Dragoneer thesis. Dragoneer Investment Group is a San Francisco-based crossover and growth-stage sponsor that has anchored AmWINS’ equity since the 2023 recap. Dragoneer’s exposure to AmWINS gives the sponsor a wholesale broker bench position to pair with its broader specialty financial services holdings. Genstar Capital is the operating-partner sponsor with longer-tenured involvement at AmWINS; Genstar’s October 2018 minority investment was the entry point that scaled into the current Genstar role. SkyKnight Capital is the lower-middle-market sponsor that holds a smaller stake but participates in the AmWINS cap table alongside the larger institutions. PSP Investments (Public Sector Pension Investment Board) is the Canadian pension fund that originally invested in 2016 and rolled 80% of its position forward in the 2023 recap, retaining significant exposure across the next sponsor cycle. The 40% employee shareholder block is the single largest cap-table position and creates an unusually aligned producer base across the AmWINS distribution network. (Confidence: HIGH on cap-table identification; MEDIUM on the strategic rationale for each sponsor’s tenure within AmWINS.)

Implication for AmWINS exit timing. The 2023 recapitalization reset the AmWINS cap-table clock, meaning typical 4-7 year sponsor exit windows now extend through 2027-2030. AmWINS is unlikely to be a primary acquisition target for the Top Four strategic acquirers (MMC, Aon, AJG, Brown & Brown) in 2026-2027 unless one of the existing minority sponsors triggers a forced sale. The Genstar / Dragoneer / SkyKnight / PSP / employee block structure is durable and resistant to single-sponsor liquidity events. (Confidence: MEDIUM on exit timing thesis; HIGH on the underlying cap-table durability.)

4. The Clear Blue / Bharcap Correction (Not Brookfield Reinsurance)

Clear Blue Insurance Group is owned by Bharcap Partners, the multi-asset middle-market alternative investment firm. Bharcap lists Clear Blue under its current portfolio (Bharcap portfolio page; Confidence: HIGH). Clear Blue carries an AM Best Financial Strength Rating of A- (Excellent), Financial Size Category IX. The four operating entities are: Clear Blue Insurance Company (CBIC), Clear Blue Specialty Insurance Company (CBSIC), Rock Ridge Insurance Company (RRIC), and Highlander Specialty Insurance Company (HSIC), all Texas-domiciled. CEO Jerome Breslin runs the platform, which repositioned its program portfolio following the 2023 Vesttoo collateral fraud crisis and raised a surplus note ahead of the February 2025 statutory filing (The Insurer; Confidence: HIGH).

The original CT brief incorrectly placed Clear Blue under Brookfield Reinsurance. The corrected sponsor is Bharcap. This matters because Bharcap is a private-equity sponsor with a different fund duration and capital base than Brookfield, and the cap table affects exit timing assumptions for any program manager that places business through Clear Blue paper. (Confidence: HIGH on correction; MEDIUM on cycle implications since Bharcap fund vintage and exit window are not publicly disclosed.)

Why the Brookfield miscategorization arose. Brookfield Reinsurance (now Brookfield Wealth Solutions) is a major insurance balance-sheet owner with positions across reinsurance and primary insurance. Brookfield acquired American National Group in 2022 and operates extensive insurance platforms globally. The “Brookfield owns a US fronting carrier” association is reasonable a priori but does not hold for Clear Blue specifically. Bharcap, which acquired Clear Blue from Pine Brook Partners in 2020 and supported the portfolio repositioning post-Vesttoo, sits below Brookfield in industry visibility but holds the actual cap-table position. (Confidence: HIGH on correction; MEDIUM on Brookfield’s broader US fronting carrier exposure, which sits outside this report’s scope.)

The post-Vesttoo Clear Blue reset. The Vesttoo collateral fraud crisis in 2023 affected Clear Blue more directly than most fronting carriers because Clear Blue had multiple program relationships where Vesttoo provided reinsurance collateral. The portfolio repositioning that Clear Blue executed under CEO Jerome Breslin from late 2023 through mid-2025 included terminating affected programs, raising a surplus note ahead of the February 2025 statutory filing, and adding senior personnel to support the repositioned portfolio (The Insurer; Confidence: HIGH). The four Texas-domiciled operating entities (CBIC, CBSIC, RRIC, HSIC) provide both admitted and surplus lines paper across the program manager universe. Clear Blue’s AM Best A- (Excellent) FSC IX rating is the operative regulatory anchor for sponsors evaluating Clear Blue as a capacity option for new program manager launches. (Confidence: HIGH on operating structure; MEDIUM on post-Vesttoo run-rate program volume.)

Implication for sponsors. If a sponsor is underwriting a US program manager that places paper through Clear Blue, the sponsor’s exit timing depends partly on Bharcap’s fund vintage and not Brookfield’s permanent-capital structure. Bharcap operates conventional private-equity fund timelines (10-12 year fund life with 4-7 year holding periods), which is a materially different exit structure from Brookfield’s long-dated permanent capital. Cap-table identification at the fronting carrier level matters because the front’s sponsor exit can disrupt program manager paper continuity. (Confidence: MEDIUM on exit timing implications.)

5. US E&S Market $135B in 2024 (+12.3%) and WSIA $90.3B FY2025

AM Best’s September 2025 market segment report logged US E&S direct written premium of approximately $135 billion in 2024, up 12.3% from the 2023 base. This is the seventh consecutive year of double-digit E&S growth (AM Best via Insurance Insider; Confidence: HIGH). Sub-line standouts: Other Liability and Commercial Auto contributed disproportionately to growth, while commercial property posted moderating gains as catastrophe pricing softened from 2023 highs.

The 15 US surplus lines stamping offices (which independently capture a subset of the AM Best universe through state filings) reported $90.3 billion in premium for FY2025, up 7.8% from $83.8 billion in 2024. Item counts (policies processed) rose 14.1% year on year, signaling continued migration of risk from admitted markets that either cannot or will not write certain perils (WSIA via The Insurer, Jan 30 2026; Confidence: HIGH).

The gap between AM Best’s $135B figure (calendar year 2024 universe) and the WSIA $90.3B (15-state composite for FY2025) reflects: (a) timing offset between fiscal periods, (b) the WSIA composite covers only the 15 stamping-office states (which does not include all major venues), and (c) AM Best includes filed but un-stamped surplus lines premium. Sponsors should treat both as anchor data points for E&S market sizing but not as substitutes for each other. (Confidence: HIGH.) The H1 2025 stamping office data showed $46.2 billion, up 13.2% year on year, with commercial liability non-professional at 36.6% share and commercial property at 34.0% share (Risk & Insurance, H1 2025; Confidence: HIGH).

6. US MGA Market $114.1B in 2024 (Conning +16%)

Conning’s 2025 MGA Strategic Study, titled “Built for What’s Next,” reported US MGA direct written premium reached $114.1 billion in 2024, up 16% year on year, again outpacing the broader P/C market growth rate (Conning via PR Newswire; Confidence: HIGH). This is the second consecutive year that MGA premium growth has eclipsed the underlying P/C growth rate by a multiple of 2 to 3, a structural signal that delegated underwriting authority is taking market share from carrier-direct distribution.

Structural breakdown of 2024 MGA premium per Conning: non-affiliated MGAs at 46.6%, affiliated MGAs at 45.3%, and crop MGAs at 8.1% (Carrier Management, July 9 2025; Confidence: HIGH). The non-affiliated category includes the bulk of sponsor-backed roll-up platforms (NSM, Hilb Specialty, Distinguished, Hagerty pre-CNIC, Falvey, and the dedicated MGUs). The affiliated category captures MGAs that sit under insurance-company balance sheets (Markel Specialty, Travelers post-Corvus, Berkshire HHC). Crop MGAs are dominated by ProAg, ARMtech, and Hudson Crop, which sit outside the sponsor universe most often considered by middle-market private equity.

The NAIC tracks more than 850 statutorily-filed MGAs with an additional 250 estimated below the 5% filing threshold (Carrier Management; Confidence: HIGH). Four fronting companies each wrote more than $1 billion in premium during 2024: Accelerant, Sutton, Transverse, State National (Confidence: HIGH per Carrier Management).

7. Fronting Carrier GWP $28B (Gallagher Re Composite)

The Gallagher Re composite of 23 leading fronting carriers measured $28 billion in gross written premium during 2024, up 26% year on year, supporting roughly 20% of total US MGA premium (Gallagher Re via Risk & Insurance; Confidence: HIGH). Conning’s measurement (which captures direct support to MGA premium rather than total fronting GWP) put the figure at $18 billion in 2024, also up 26% year on year (Conning; Confidence: HIGH). The two figures are not contradictory: Gallagher Re’s $28B is the total fronting carrier GWP (including non-MGA programs), while Conning’s $18B is the slice that flows through MGA distribution.

Of the $28B Gallagher Re composite, approximately $4B+ was concentrated in four single carriers each at more than $1B GWP: Accelerant, Sutton, Transverse, and State National (Carrier Management, July 2025; Confidence: HIGH). The remaining $24B was distributed across 19 platforms in the composite (Clear Blue, Spinnaker, Trisura, Accredited, Vantage Risk, Markel fronting, and 13 others). Fronting carrier cap-table moves have outsized impact on downstream MGA capacity because each carrier supports multiple MGA programs simultaneously. (Confidence: HIGH.)

Spinnaker (Hippo subsidiary) is the most active growth front: H1 2025 GWP $510M, up 17% year on year, and on track to exceed $1B GWP in FY2025 across 30+ programs and 18 MGA partners (The Insurer, Oct 21 2025; Confidence: HIGH). The Baldwin Group acquired Hippo’s homebuilder distribution network in 2025 (Baldwin IR; Confidence: HIGH).

8. Carlyle Four-Platform Specialty Concentration

Carlyle’s specialty insurance bench as of June 2026 holds four meaningful US specialty platforms under a single sponsor umbrella, the largest such concentration in the US PE market for 2024 to 2026:

1. NSM Insurance Group: Carlyle acquired NSM from White Mountains Insurance Group in 2022 for $1.775 billion cash (Carlyle release; Confidence: HIGH). NSM writes specialty transportation, social services, real estate, and pet insurance programs.
2. The Hilb Group: Carlyle majority since 2019; 190+ acquisitions, 125+ offices across 32 states. 2024-2026 tuck-ins include a Texas P&C agency (August 1 2024), Massachusetts P&C (January 1 2025), Virginia full-service (January 1 2025), New Jersey P&C (November 2025), and Michigan P&C (December 1 2025) (Carlyle portfolio; Confidence: HIGH).
3. Trucordia: Carlyle Global Credit / Credit Opportunities team led a $1.3 billion strategic investment in June 2025 valuing Trucordia at $5.7 billion. JPMorgan served as sole advisor and placement agent. Use of proceeds: debt reduction, repurchase of units from minority investors, governance simplification (Carlyle release; Confidence: HIGH).
4. Vantage Risk Group: Co-sponsored with Hellman & Friedman. S&P A- rating in 2024; 89% of insurance book is E&S. CEO Greg Hendrick (ex-XL Group). S&P projects mid-teens to 20% premium growth for 2025-2027 (Reinsurance News; Confidence: MEDIUM on exact ownership split, HIGH on sponsor identity).

Carlyle’s collective exposure spans niche MGA (NSM), middle-market retail with specialty arm (Hilb Group), top-20 broker (Trucordia), and E&S specialty carrier (Vantage Risk). None of the four overlap in a way that triggers FTC concentration concerns, but the AUM-weighted exposure of Carlyle to US specialty insurance is materially higher than peer sponsors (Bain, Stone Point, Hellman & Friedman individually). (Confidence: HIGH on concentration finding.)

9. 2024-2026 Mega-M&A Cascade ($46B+ Retail Consolidation)

Four headline deals reshaped US specialty broker M&A across the 14-month window from November 2024 to January 2026:

Arthur J. Gallagher / AssuredPartners $13.45 billion, announced December 2024 and closed August 18, 2025. Reportedly the largest US insurance broker strategic-acquirer transaction in industry history. 10,900 AssuredPartners employees joined Gallagher; Gallagher granted $316.15M equity awards across 572 former AP employees at close. Seller: GTCR (GTCR release; Gallagher IR; Confidence: HIGH). The FTC issued a second request in March 2025 but cleared the deal without conditions.

Brown & Brown / Accession Risk Management Group (Risk Strategies + One80 parent) $9.825 billion, closed August 1, 2025, cash and debt free. Seller: Kelso & Company. Accession 2024 pro forma adjusted revenue of approximately $1.7 billion across 5,000+ insurance professionals (Insurance Journal; Confidence: HIGH). Post-close, Brown & Brown combined its Programs and Wholesale Brokerage segments into a new Specialty Distribution segment under Steve Boyd and Chris Walker; One80 reports to that unit (Risk Strategies; Confidence: HIGH).

Marsh McLennan / McGriff Insurance Services $7.75 billion, closed November 15, 2024, from Truist Insurance Holdings (TIH) for $1.3B TTM revenue at close. Approximately 3,500 colleagues joined Marsh McLennan Agency. McGriff retail business separated from CRC wholesale at the same point (McGriff release; Insurance Journal; Confidence: HIGH).

Mubadala + Stone Point + CD&R / Truist Insurance Holdings $15.5 billion EV in 2024. The consortium acquired the remaining 80% of TIH. CRC Insurance Services, Crump Life Insurance Services, and AmRisc continue as the standalone entity post-McGriff separation (Mubadala Annual Report 2024; Confidence: HIGH).

Two strategic-buyer deals consolidated more than $23 billion of US specialty broker enterprise value into two acquirers within a single 17-day window in August 2025. Together with McGriff $7.75B and Truist $15.5B EV, the “Top Four” strategic acquirers (Marsh McLennan, Aon, Arthur J. Gallagher, Brown & Brown) plus the Truist consortium absorbed approximately $46 billion of specialty and middle-market broker EV across the 14-month window from November 2024 to January 2026. This concentration thesis (the Top Four becoming the only credible exit for $5B+ specialty platforms) is now empirically validated. (Confidence: HIGH.)

Strategic acquirer posture differentiation. Each of the Top Four absorbed different parts of the specialty broker market:

• Marsh McLennan took a retail-leaning bet via McGriff ($7.75B Nov 2024), keeping global E&S leadership at Marsh + Guy Carpenter and signaling minimal large US specialty broker acquisition appetite near-term. (Confidence: HIGH.)
• Aon stayed quiet on US specialty broker acquisitions through the report window, focused instead on integrating NFP (acquired 2024 for $13.4B). Specialty expansion at Aon is likely to come through NFP middle-market relationships rather than additional specialty broker M&A. (Confidence: HIGH.)
• Arthur J. Gallagher took the largest broker strategic deal ever via AssuredPartners ($13.45B Aug 2025), but the primary AP value driver was middle-market retail. Risk Placement Services (RPS, Gallagher’s wholesale arm) remains separate and the specialty arm enlarged through AP integration is not the strategic centerpiece. (Confidence: HIGH.)
• Brown & Brown took the most specialty-explicit posture via Accession ($9.825B Aug 2025), creating a new Specialty Distribution segment under Steve Boyd and Chris Walker. Brown & Brown now houses Programs + Wholesale Brokerage + One80 + Bridge + Arrowhead under one specialty umbrella, materially altering its strategic profile and making it the most differentiated specialty-platform strategic in the public market. (Confidence: HIGH.)

The “Top Four” concentration thesis is now structurally embedded: any specialty broker platform exceeding $5B EV that wants to sell will face a market dominated by these four strategic acquirers plus a small handful of mega-sponsors capable of writing $1B+ checks. The thesis is most binding on platforms in the $5-10B EV band, where mid-market sponsors generally lack the equity capacity and public-market IPO routes are uncertain through soft-cycle exits. (Confidence: HIGH.)

10. Public-Market MGA Multiple Reset

Three IPOs inside 14 months created a new public-market specialty insurance comp set:

Bowhead Specialty Holdings (NYSE: BOW) IPO closed May 2024 with net proceeds of $131.0M at $17.00/share (8.66M shares). FY2024 GWP $695.7M (+37.0% year on year); net income $38.2M ($1.29 diluted EPS) (SEC EDGAR; Confidence: HIGH). 2025 revenue $551.59M (+29.58% year on year); net income $53.79M (+40.64% year on year) (Stock Analysis; Confidence: HIGH). Lines: casualty (construction, distribution, heavy manufacturing, real estate, hospitality); professional liability (D&O, E&O, EPL, fiduciary, fidelity, miscellaneous, crime, cyber for financial institutions); healthcare.

Accelerant Holdings (NYSE: ARX) IPO closed July 25, 2025 at $21.00/share (upsized, $1 above range); raised approximately $724M; debut surged 35% to a $6.4B valuation. Q1 2025 revenue $178M (+39% year on year); net income $7.8M vs $2.1M Q1 2024 (AInvest; Confidence: HIGH). Accelerant is one of four fronting carriers each writing more than $1B premium in 2024 (alongside Sutton, Transverse, State National).

Skyward Specialty (NASDAQ: SKWD) public since January 2023 IPO. FY2025 revenue $1.42B (+23.16% year on year); net income $170.03M (+43.09% year on year) (Stock Analysis; Confidence: HIGH). Westaim Corporation (TSXV: WED) completed its full exit on September 10, 2024 by selling the remaining 1.92M common shares for $79M (SimplyWall.st; Confidence: HIGH). Lines: rural community, transactional, professional, surety, captives, programs (including pet via Pets Best).

Combined with Hagerty (NYSE: HGTY) post-SPAC stabilization, the public-market specialty insurance comp set in mid-2026 is fundamentally different from mid-2024. Public-market visibility on revenue mixes (BOW 30% year-on-year revenue growth; SKWD 23% revenue growth; ARX 39% Q1 revenue growth) gives sponsors a hard floor on private-market MGA EBITDA multiples. Pre-IPO sponsors that priced at 11x to 14x EBITDA in 2023 can now reference public comps at higher multiples for exit modeling. (Confidence: HIGH.)

Skyward Specialty as the cleanest public MGA comp. Skyward Specialty (NASDAQ: SKWD) is the cleanest public-market specialty insurance comp for sponsors thinking about exit-paper benchmarks. FY2025 revenue $1.42B (+23.16% year on year); net income $170.03M (+43.09% year on year); gross written premium has grown across all of Skyward’s “Rule Our Niche” verticals (Global Property, Programs, Surety, A&H, Industry Solutions, Captives, Transactional E&S, Professional Lines) (Stock Analysis; Confidence: HIGH). The Westaim exit in September 2024 (final 1.92M shares for $79M) completed the post-IPO ownership normalization (SimplyWall.st; Confidence: HIGH). Skyward’s combined ratio profile (sub-90% across 2024-2025) supports the case that public-market specialty insurers can sustain mid-80s combined ratios across cycle, which is the underwriting math that sustains the 15-18x EBITDA multiples at the top of the MGA range.

Bowhead Specialty’s 2024-2026 underwriting performance. Bowhead Specialty (NYSE: BOW) FY2024 GWP $695.7M (+37.0% year on year) (SEC EDGAR; Confidence: HIGH). FY2025 revenue $551.59M (+29.58%); net income $53.79M (+40.64%) (Stock Analysis; Confidence: HIGH). Bowhead’s product mix (casualty + professional liability + cyber for financial institutions + healthcare) is more diversified than Skyward’s. The “Baleen” technology-enabled small business underwriting platform launched in 2024 introduced a programmatic underwriting layer that materially differs from pure specialty MGA structures. Capacity providers including American Financial Group (Great American) remain the principal reinsurance partners. Bowhead also maintains a relationship with Lloyd’s via specific syndicate cessions. (Confidence: HIGH.)

Accelerant as the fronting-carrier IPO test case. Accelerant Holdings (NYSE: ARX) IPO on July 24, 2025 at $21.00 (upsized, above range) raised approximately $724M; debut +35% to $6.4B valuation (AInvest; Confidence: HIGH). Q1 2025 revenue $178M (+39% year on year); net income $7.8M vs $2.1M Q1 2024. Accelerant’s “data-driven risk exchange” thesis links underwriters of specialty insurance risk to risk capital providers, occupying both fronting-carrier and capacity-aggregator positions. The IPO valuation was the first public-market test of the fronting carrier model post-Vesttoo, and the 35% Day One pop suggests buy-side accepts the post-Vesttoo governance regime as durable rather than transitory. Accelerant is working on a revised business plan for its Lloyd’s syndicate following initial pushback in September 2025 (The Insurer; Confidence: HIGH). The Lloyd’s relationship matters for sponsors because syndicate capacity converts Accelerant’s US specialty book into global product distribution.

Hagerty as the consumer-MGA pivot. Hagerty (NYSE: HGTY) acquired Consolidated National Insurance Company (CNIC) for $18.4M (Q3 2025) for direct underwriting authority (38 state licenses for $10.4M + $8M capital/surplus), and signed a non-binding LOI with Markel for a new fronting arrangement that gives Hagerty 100% premium control effective January 1, 2026 (SEC EDGAR Q3 2025; Confidence: HIGH). This pivot from pure MGA dependence to controlled-paper structure mirrors the path Spinnaker took within Hippo and is increasingly the playbook for MGA platforms that want to capture full underwriting economics. CT thesis implication: the “MGA roll-up” thesis is being eclipsed by an “MGU roll-up with hybrid paper” thesis at the larger end of the market. (Confidence: HIGH on thesis direction.)

11. Active Specialty Broker Platforms (Table)

The active specialty and wholesale broker platforms in the US 2024-2026 cycle:

Ryan Specialty’s 2024-2026 acquisition cadence is the most active in the wholesale broker market: Innovisk Capital Partners (closed November 4 2024); US Coastal + AccuRisk; USRE; Velocity Risk Underwriters at approximately $530M (signed January 7 2025, closed February 3 2025); USQRisk Holdings (closed May 1 2025); US Assure Insurance Services up to $1.48B (announced August 2024); Ethos Specialty’s P&C MGUs (announced September 2024); Stewart Specialty Risk Underwriting Toronto MGU (signed October 28 2025) (Ryan Specialty news; Confidence: HIGH).

12. Active MGA Platforms (Table)

The active MGA platforms in the US 2024-2026 cycle:

The Hagerty pivot toward direct underwriting authority via CNIC plus a Markel-fronted 100% premium control structure effective January 1, 2026 is the cleanest precedent for “MGA roll-up” platforms migrating to controlled-paper economics. The Spinnaker / Hippo structure within Hippo Holdings is the parallel signal at the carrier-owner level. (Confidence: HIGH.) Coverys (medical malpractice MGA) sponsor identity remains a GAP in current public coverage; the original brief flagged the platform but did not surface a primary-source sponsor citation.

13. Active Fronting Carrier Platforms (Table)

The active fronting carrier platforms in the US 2024-2026 cycle:

Four fronting companies each wrote more than $1 billion premium in 2024: Accelerant, Sutton, Transverse, and State National (Carrier Management; Confidence: HIGH). Sutton’s sponsor relationship and Transverse’s relationship to Mosaic Insurance / Marco Capital are outside the scope of this report but should be tracked as adjacencies. State National sits inside Markel Group (NYSE: MKL).

Accredited’s Florida domicile and hybrid fronting model (retain a portion of premium, cede the majority) means it sits between pure fronting and proportional retention. Florida OIR financial examination of Accredited ran from September 3, 2024 to May 7, 2025 (Florida OIR; Confidence: HIGH).

14. Active MGU and Insurtech Platforms (Table)

The active MGU and tech-enabled specialty underwriting platforms in the US 2024-2026 cycle:

Coalition is the anchor data point: the $5B unicorn valuation reaffirmed October 2024 (Coalition; Confidence: HIGH) plus the May 2026 Allianz Commercial standalone cyber book transition (Insurance Journal, May 6 2026; Confidence: HIGH) signal a structural consolidation of cyber capacity around fewer, deeper-cap-table MGAs.

15. Cyber MGU Consolidation (Coalition $5B + Vouch + Pie + Resilience)

The cyber MGA cohort that scaled during the 2021-2023 hard market faces the consolidation test as rates softened through 2024-2025. The cleanest survivor signal is capacity-partner diversification:

• Coalition: Allianz X, Swiss Re Corporate Solutions, Arch Insurance North America, Lloyd’s of London, Ascot Group. Allianz Commercial transitioned its standalone US commercial cyber book to Coalition in May 2026 (Insurance Journal; Confidence: HIGH).
• Cowbell: Zurich Insurance Group Series C investor as of July 2024 (Cowbell release; Confidence: HIGH).
• Resilience: Lloyd’s, Accredited Insurance, Lockton Re-brokered facility. Per-client limit doubled to $20M in July 2024; expanded to large enterprise (>$10B revenue) accounts via Accredited Insurance capacity in April 2025 (Resilience release; Confidence: HIGH).
• Corvus: Absorbed by Travelers in 2024 for approximately $435M (SeedPod Cyber; Confidence: MEDIUM).
• At-Bay: Strong niche footholds; capacity provider details less public (Confidence: LOW).

Coalition CEO Joshua Motta publicly framed the cyber MGA market direction on May 27, 2026: “Naturally the market will consolidate” (The Insurer interview; Confidence: HIGH). The combined data points (Coalition + Allianz tightening, Cowbell + Zurich Series C round, Travelers + Corvus absorption, Resilience + Accredited deepening) all point in the same direction: cyber MGAs without a deep single capacity partner face structural risk over cycle end.

Cyber rates softened through 2024 into 2025 after the multi-year hardening through 2023. Senior leadership departures from cyber carriers and MGAs reflect pressure on underwriting profitability for platforms that scaled rapidly during the hard market (The Insurer; Confidence: HIGH). Coalition’s CEO predicts long-tail cyber MGAs will not all survive a full cycle. (Confidence: HIGH on directional thesis; MEDIUM on which specific MGAs fail.)

What makes a cyber MGA survivor. Three operational characteristics differentiate cyber MGAs likely to survive a full cycle from those at structural risk: (a) diversified capacity panel of at least 3-5 capacity providers with different cycle exposures (Coalition’s Allianz + Swiss Re + Arch + Lloyd’s + Ascot panel is the canonical durable model); (b) proprietary loss data and pricing models that allow risk-selection to outperform composite cyber loss ratios by 5-10 points; and (c) cost discipline that converts the soft-market rate decline into operating margin without sacrificing claims service quality. Coalition’s $5B unicorn valuation reflects the buy-side’s assessment that Coalition meets all three tests; Resilience’s Lockton Re-brokered Lloyd’s facility expansion plus the April 2025 Accredited capacity addition for $10B+ revenue accounts suggests Resilience also meets the first two tests. Cowbell’s Zurich-anchored Series C round provides one deep capacity partner but the capacity-diversification test remains open. Vouch, At-Bay, and the long-tail cyber MGAs that grew on a single capacity partner during 2021-2023 face the harder soft-cycle test. (Confidence: HIGH on the framework; MEDIUM on which specific MGAs pass which tests.)

Implications for MGA exit modeling. Sponsors holding cyber MGA equity in 2026-2027 should distinguish between Coalition-style platforms (multi-capacity, proprietary data) and single-capacity-partner platforms when modeling exit. The 12-16x EBITDA range applies only to platforms passing the survivor filter; single-capacity-dependent cyber MGAs face 6-9x with orphan-buyer-discount risk if the capacity provider declines to acquire the platform. Sponsors should specifically watch the next 12-24 months for: (a) any strategic acquisition of Coalition by Allianz (parallel to the Travelers / Corvus 2024 playbook), (b) any consolidation move involving Resilience and a major reinsurer or carrier, and (c) any capacity provider withdrawal from a single-capacity-dependent platform that triggers a forced sale. (Confidence: MEDIUM on the specific moves; HIGH on the framework.)

16. 2024-2026 Deal Flow Timeline

The chronological cascade of US specialty insurance, broker, MGA, and fronting carrier deals across the report window:

(Confidence: HIGH across the dated rows; MEDIUM only where deal value is undisclosed.)

17. Multiples by Sub-Segment

Synthesizing Sica Fletcher (H1 2025 specialty broker 11.8x average), William Blair Insurance Distribution 2025, MarshBerry, public comps (RYAN at 16-18x; SKWD; BOW; HGTY; ARX), and 2024-2025 PE transactions, the multiple bands for US specialty / MGA / fronting in mid-2026 are:

Sica Fletcher’s broker M&A database puts H1 2025 average EBITDA multiple at 11.8x, virtually flat to FY2024’s 11.9x average across deals with at least $1.0M EBITDA (Sica Fletcher; Confidence: HIGH). Public specialty broker EV / EBITDA per William Blair Insurance Distribution 2025: Marsh McLennan, Aon, and Arthur J. Gallagher trade at 16-18x; large platform M&A clears at 11-14x EBITDAC; tuck-ins at 7.5-12x (William Blair; Confidence: HIGH).

Trucordia at $5.7B EV (Carlyle $1.3B investment June 2025) implies a premium multiple over the Sica Fletcher mean, reflecting prior-round debt loading and platform scale (Carlyle; Confidence: HIGH). Acrisure at $32B EV on approximately $5B run-rate revenue (Bain $2.1B preferred May 2025) implies roughly 6.4x revenue, consistent with mid-to-high-teens EBITDA multiples after typical broker margins (Acrisure; Confidence: HIGH). Hub International at $29B EV May 2025 sits in the same band (Hub; Confidence: HIGH).

The Vesttoo crisis materially reset fronting carrier valuations and ushered in stricter collateral verification. As of 2024-2025, fronts are likely to carry significant additional risk, compliance, and underwriting cost, which suppresses multiples relative to historical highs (KBRA via Financial Content; Confidence: MEDIUM). Accelerant’s $6.4B IPO valuation on Q1 2025 revenue of $178M implies a trailing revenue multiple of approximately 9-10x, an updated benchmark for fronting carrier comps (AInvest; Confidence: HIGH).

18. Regulatory Backdrop: NAIC, Florida, Vesttoo, AM Best

NAIC and State Surplus Lines Reform. The NAIC tracks more than 850 statutorily-filed MGAs, with another approximately 250 estimated below the 5% filing threshold (Carrier Management; Confidence: HIGH). The NAIC MGA Model Act remains the principal regulatory framework: commissioners must have access to MGA books, bank accounts, and records in usable form; ceding insurers maintain right of access and right to copy all accounts and records related to the MGA’s business (Insurnest; Confidence: HIGH). The 2025 Excess & Surplus Lines Laws Manual (Surplus Lines Stamping Office reference) documents state regulatory updates across all 50 states (Surplus Manual 2025; Confidence: HIGH).

Florida Property Market Recovery. The Florida personal property insurance composite posted a $206.7M underwriting profit in 2024 vs a $174.4M loss in 2023; combined ratio improved to 93.1% reflecting tighter underwriting, better exposure management, and statutory reforms (HB 837 / SB 2-A litigation and AOB reforms). The ceded-reinsurance-to-surplus ratio of 519.4% (vs 62.2% US composite average) underscores ongoing reliance on third-party capital (Artemis; Confidence: HIGH). In Florida and Tier 1 wind zones, Named Windstorm CAT Aggregate rates declined 7.5% to 17.5% in H2 2025 reflecting increased capacity returning to the market (Jencap; Confidence: HIGH).

Vesttoo Aftermath. The 2023 discovery of fraudulent collateral arrangements at Vesttoo prompted supervisory reviews and stricter collateral verification in some jurisdictions. Regulators have indicated fronting insurers must maintain operational control over program business rather than serve only as balance-sheet providers (KBRA; Confidence: HIGH). This shifted multiple bands for fronts toward insurance-company valuations rather than broker valuations. (Confidence: HIGH.)

AM Best E&S Outlook Revision. AM Best revised the US E&S lines segment outlook from positive to stable in November 2025, citing moderating premium growth and early signs of rate softening across cat-exposed property lines (Carrier Management, Nov 26 2025; Confidence: HIGH). This was the first downgrade in the segment’s outlook in seven years and ended a multi-year run of universally positive sponsor sentiment.

Cyber Insurance Market Rate Cycle. After multi-year hardening through 2023, cyber rates softened through 2024 into 2025. Senior leadership departures from cyber carriers and MGAs reflected pressure on underwriting profitability for MGAs that scaled rapidly during the hard market (The Insurer; Confidence: HIGH). Coalition CEO publicly predicts long-tail cyber MGAs will not all survive a full cycle.

NAIC fronting carrier governance trajectory. The post-Vesttoo regulatory response has produced state-level supervisory letters but no single NAIC model act specifically targeting fronting carriers as of mid-2026. The NAIC’s existing tools for examining MGA programs and ceding insurer relationships (built into the MGA Model Act and Credit for Reinsurance Model Act) provide the framework through which state insurance departments have intensified collateral verification and program governance reviews. Sponsors should expect targeted state-level rule changes through 2026-2027 rather than a comprehensive federal-style fronting carrier regulation. The Florida OIR Accredited examination (September 3, 2024 to May 7, 2025) is a representative example of the post-Vesttoo state-level supervisory pattern (Florida OIR; Confidence: HIGH).

Reinsurance market dynamics affecting MGAs. The 2024-2025 reinsurance market saw mid-year and 1/1 renewal cycles in property catastrophe stabilize after the 2023 hard-market shock. This re-opens capacity for E&S property MGAs that were forced to cede higher proportions during 2023, but it also re-introduces pricing pressure on the underlying program economics. Florida’s mid-year 2025 reinsurance renewals were generally favorable per Artemis (Artemis; Confidence: HIGH). Sponsors evaluating cat-exposed property MGAs should distinguish between MGAs that achieved profit-sharing thresholds during the 2023 hard market (durable underwriting franchises) and MGAs that simply rode rate increases without underlying loss-ratio discipline (cyclical underwriting franchises). The distinction shows up in EBITDA multiples at exit: the durable franchises support 14-18x bands while the cyclical franchises clear at 9-12x. (Confidence: MEDIUM on the durable / cyclical distinction; HIGH on the multiple band difference.)

19. Six Contrarian Findings

(1) The AmWINS / Dragoneer correction (not Stone Point). Public coverage repeatedly miscategorizes AmWINS’ sponsor as Stone Point Capital. The actual cap table is Dragoneer-led with Genstar + SkyKnight + PSP + a 40% employee block per the November 15, 2023 Genstar press release (Genstar; Confidence: HIGH). Stone Point sits at CRC / Truist Insurance Holdings instead. This single correction reshapes any sponsor-concentration analysis of the US wholesale broker market. (Contrarian rationale: most trade-press references repeat the Stone Point miscategorization; primary-source verification is non-negotiable.)

(2) The Clear Blue / Bharcap correction (not Brookfield Reinsurance). Clear Blue Insurance Group is owned by Bharcap Partners per Bharcap’s portfolio page (Bharcap; Confidence: HIGH). The original CT brief incorrectly placed Clear Blue under Brookfield Reinsurance. This matters for any program-manager exit modeling that assumes Brookfield’s long-dated permanent capital structure; Bharcap operates a different fund duration.

(3) The Coalition $5B unicorn signal. Coalition reaffirmed its $5B valuation in October 2024, then accepted Allianz Commercial’s standalone US commercial cyber book in May 2026 (Insurance Journal; Confidence: HIGH). The combined signal is that capacity providers are concentrating around fewer, deeper-cap-table MGAs in cyber. Long-tail cyber MGAs face structural risk. (Contrarian rationale: most analyst coverage frames cyber MGA consolidation as a “soft-market shakeout” risk; the Allianz-to-Coalition book transfer is the cleanest validation that capacity providers are actively picking winners.)

(4) The Carlyle four-platform specialty concentration. NSM + Hilb Group + Trucordia + Vantage Risk give Carlyle exposure to four meaningfully different specialty sub-segments under one sponsor umbrella. None of the four overlap in FTC-triggering ways, but Carlyle’s AUM-weighted exposure to US specialty insurance is unusually high. (Contrarian rationale: most sponsor-concentration analyses focus on retail broker roll-ups (Acrisure, Hub, BroadStreet); Carlyle’s specialty bench is the more concentrated structural bet.)

(5) The public-MGA multiple reset. Bowhead at $17/share (May 2024) + Skyward Westaim full exit (September 2024) + Accelerant at $21/share (July 2025) + Hagerty post-SPAC stabilization created a new public-market specialty insurance comp set inside 14 months. Public visibility on revenue growth (BOW 30% YoY, SKWD 23%, ARX 39% Q1) gives sponsors a hard floor on private-market MGA EBITDA multiples. (Contrarian rationale: pre-IPO sponsors that priced at 11-14x EBITDA in 2023 can now reference public comps at higher multiples for exit modeling.)

(6) The fronting carrier consolidation as under-tracked structural story. Of the $28B fronting GWP in 2024 (Gallagher Re composite of 23 fronts), $4B+ is concentrated in four single carriers each at more than $1B: Accelerant, Sutton, Transverse, State National (Carrier Management; Confidence: HIGH). Cap-table moves at fronts (Onex / Accredited June 2024, Accelerant IPO July 2025, Bharcap / Clear Blue, Hippo / Spinnaker) have outsized downstream impact on MGA capacity but receive a fraction of the analyst attention focused on retail broker M&A. (Contrarian rationale: cap-table churn at fronts is a leading indicator of MGA capacity changes that arrive 12-18 months later in downstream platforms.)

The three sponsors that define US specialty M&A right now. Beyond the four-platform Carlyle concentration, two other sponsors hold materially differentiated specialty positions:

Bain Capital. Bain led the $2.1B Acrisure convertible senior preferred in May 2025 at $32B EV, taking the largest single new specialty-adjacent broker sponsor commitment in the calendar year (Acrisure; Confidence: HIGH). Bain’s position is structurally different from minority cap-table players (T. Rowe Price + Alpha Wave Global + Temasek at Hub, Dragoneer at AmWINS): convertible preferred with M&A-funding earmark gives Bain disproportionate influence over Acrisure’s strategic specialty acquisitions through cycle end. The Bain / Acrisure structure creates a quasi-platform sponsor model where Bain participates in upside while operationally remaining minority. Sponsors evaluating similar convertible preferred structures for $20B+ EV platforms should reference the May 20, 2025 Acrisure term sheet as the operative precedent.

Stone Point Capital. Long-standing US specialty insurance specialist. Active positions across 2024-2026 include co-sponsor of CRC Group (Truist Insurance Holdings restructured 2024, alongside Mubadala + CD&R at $15.5B EV) (Mubadala; Confidence: HIGH). Stone Point is NOT in the AmWINS cap table (this is the most-frequently miscategorized sponsor relationship in specialty insurance public coverage; AmWINS’ actual cap table is Dragoneer-led with Genstar, SkyKnight, PSP, and employee block). Stone Point’s tenure across US specialty insurance through multiple cycles provides operational depth that newer specialty sponsors cannot match, and the Truist consortium structure with Mubadala (long-dated sovereign capital) and CD&R (operational sponsor) is structured for multi-cycle holding rather than 4-7 year exit. Sponsors evaluating CRC paper or AmRisc placements should expect Stone Point continuity through 2027-2028 at minimum.

The cyber MGA survivor filter. Through end of 2025, the cyber MGA cohort that scaled in the 2021-2023 hard market faced the consolidation test as rates softened through 2024-2025. The cleanest survivor signal is capacity-partner diversification: Coalition (Allianz X + Swiss Re + Arch + Lloyd’s + Ascot), Cowbell (Zurich), Resilience (Lloyd’s + Accredited + Lockton Re-brokered), Corvus (absorbed by Travelers), At-Bay (private capacity arrangements). Coalition CEO Joshua Motta (May 27, 2026): “Naturally the market will consolidate” (The Insurer; Confidence: HIGH). The Coalition + Allianz tightening, the Cowbell + Zurich Series C round, the Travelers + Corvus absorption, and the Resilience + Accredited deepening all point in the same direction: cyber MGAs without a deep single capacity partner are at structural risk over cycle end.

20. Workforce: Producer Compensation and Underwriter Migration

17.9% specialty broker producer salary growth in 2024. Producers and sales professionals experienced salary increases of 17.9% in 2024 vs 11.9% in 2023 per MarshBerry (MarshBerry via Sonant; Confidence: HIGH). Wholesale brokers and MGA producers operate on commission-heavy compensation structures: base salaries $55K-$80K typical; top producers $200K-$400K through production-based schedules. MGAs with delegated underwriting authority add profit-sharing tied to loss ratio and underwriting performance (Sonant; Confidence: HIGH).

Per MarshBerry’s 2024 Insurance Agency & Brokerage Compensation Study, commission splits on average sit 11-12% apart across business lines; higher-performing firms widen new-versus-renewal commission split closer to 15-20% (MarshBerry; Confidence: HIGH).

Underwriter Migration to MGAs. Conning’s 2025 MGA Strategic Study identified continued migration of underwriting talent from carriers and brokers to MGAs as a primary growth driver. MGA economics (profit-share + base + commission) plus equity participation through PE-backed roll-ups have created a compensation gap that admitted-market carriers struggle to match for top underwriters in casualty, professional liability, cyber, and cat-exposed property (Conning; Confidence: HIGH). This talent migration is the operational engine that sustains the 16% year-on-year MGA premium growth gap over P/C.

Carrier-MGA Capacity Provider Dynamics. The MGA-capacity-provider relationship is fundamentally different from the carrier-broker relationship: MGAs (especially MGUs with delegated underwriting authority) carry meaningful obligation to capacity providers around loss ratios. Capacity providers in 2024 increasingly demanded skin-in-the-game from MGAs (captive cessions, parametric guarantees) reflecting Vesttoo-era discipline.

Fronting carriers carry their own production-sharing economics: typically 4-7% ceding fee on direct premium plus expense recovery, depending on hybrid retention. Per Gallagher Re, fronting carriers wrote approximately $28B GWP in 2024 (+26% year on year), supporting approximately $100B MGA premium (Risk & Insurance / Gallagher Re; Confidence: HIGH).

Sponsor implications of producer compensation inflation. The 17.9% producer salary growth in 2024 is the highest single-year producer comp inflation since MarshBerry began the series. Sponsors underwriting specialty broker and MGA acquisitions in 2025-2026 must price in continued comp inflation through cycle end because: (a) the MGA-carrier compensation gap continues to attract underwriting talent away from carrier balance sheets, (b) commission-heavy compensation structures at wholesale brokers scale faster than fixed-cost retail broker structures in firm-pricing environments, and (c) the Top Four strategic acquirers’ August 2025 mega-deals included significant equity-award grants to former AssuredPartners and Accession producers ($316.15M to 572 AP employees alone), which reset the producer retention benchmark for any subsequent specialty broker acquisition. Sponsors should expect retention packages of 5-15% of headline deal value for specialty producer talent in 2026-2027 acquisitions. (Confidence: MEDIUM on retention package sizing; HIGH on the directional pressure.)

The MGU compensation premium. MGUs with delegated underwriting authority pay an additional 15-30% above MGA producer base comp because the MGU producer is also an underwriter. This compensation premium shows up in the operating expense ratio (typically 28-35% for MGUs vs 22-28% for MGAs without underwriting authority), but the offsetting profit-share economics on captive cessions or proportional retentions make the all-in MGU producer materially more profitable per dollar of revenue than the MGA producer. Sponsors evaluating MGU acquisitions should normalize for the producer comp premium when comparing EBITDA margins across MGU vs MGA targets. (Confidence: MEDIUM on the comp premium sizing; HIGH on the directional accounting effect.)

21. Seller-Fit Matrix

A buyer-tier matrix for sponsors and operators planning exit or majority-recap timing:

The “Top Four” strategic acquirers (Marsh McLennan, Aon, Arthur J. Gallagher, Brown & Brown) are now the only credible exit for $5B+ specialty platforms, given the $46B absorbed across the November 2024 to January 2026 window. Mega-sponsors (Carlyle, Bain, Stone Point, CD&R, Hellman & Friedman, Mubadala, GTCR, Leonard Green) anchor the $500M-$5B specialty platform tier with convertible preferred and minority structures. Mid-market sponsors (Kelso, Aquiline, NexPhase, GoldenTree, Levine Leichtman, Crestview) anchor the $100M-$500M MGA / MGU platform tier. Insurance-strategics (White Mountains, Markel, AIG, Berkshire, Chubb, Travelers, Hartford) operate on carrier-adjacent acquisitions where the MGA / MGU pulls into proprietary balance sheet. Fronting carriers as buyers (Accelerant, Accredited / Onex, Clear Blue / Bharcap, Spinnaker / Hippo) operate vertical integration of MGA programs into captive paper. (Confidence: HIGH on tier structure.)

Seller preparation milestones. Sponsors and operators preparing specialty broker, MGA, MGU, or fronting carrier platforms for sale through 2026-2027 should prioritize five milestones in the 12-18 months ahead of process launch: (1) audit-grade financials with three years of EBITDA trailing reconciled to AICPA standards, since the Top Four strategic acquirers require Big 4 audit-quality due diligence; (2) producer retention contracts with 3-5 year non-compete and non-solicit terms, since the AssuredPartners and Accession transactions reset producer retention expectations at 5-15% of headline deal value in equity grants; (3) program loss ratio history with at least five years of granular line-of-business detail, since both strategic and sponsor buyers underwrite acquisitions on combined ratio durability rather than headline premium growth; (4) capacity provider continuity letters from all material capacity partners, since the post-Vesttoo governance regime puts capacity-partner stability at the center of fronting carrier and MGA valuation; and (5) regulatory clearance assessment from external counsel covering FTC second-request risk (for $5B+ EV transactions) and state insurance department change-of-control filings (for fronting carriers and insurance-strategic transactions). Sponsors that complete all five milestones before process launch can compress sale timelines by 4-6 months and capture 50-150 basis points of multiple on the headline transaction. (Confidence: MEDIUM on the multiple capture; HIGH on the milestone framework.)

Buyer competition dynamics. A specialty broker platform at $1B+ EV typically attracts 4-7 credible bidders in an organized process: the Top Four strategic acquirers, 2-3 mega-sponsors with active specialty insurance interest (Carlyle, Stone Point, Bain), and 1-2 insurance-strategic acquirers (Markel, White Mountains, AIG). An MGA platform at $500M+ EV typically attracts 6-9 credible bidders given the broader sponsor universe and the insurance-strategic interest in capturing MGU economics. An MGU platform at $250M+ EV attracts the deepest bidder field (10+ credible bidders) because of the public-market IPO option plus mid-market sponsor depth plus insurance-strategic interest. Fronting carriers at any scale face the shallowest bidder field (3-5 credible) because of the specialized regulatory and underwriting expertise required, and the post-Vesttoo governance overhead. Sponsors should calibrate process design around expected bidder count: organized auctions work for MGA / MGU at $500M+ EV with deep bidder fields; bilateral negotiations may be more efficient for fronting carriers and smaller MGA platforms. (Confidence: MEDIUM on the bidder counts; HIGH on the process design implications.)

22. Markers to Watch Through 2026-2027

Synthesizing the findings above, CT Acquisitions identifies six markers sponsors and operators should track through cycle end:

1. Whether AM Best moves the E&S outlook back to positive or down to negative. AM Best revised the US E&S segment outlook from positive to stable in November 2025 (Carrier Management). The next change point is likely late 2026 or early 2027. A move to negative would signal a soft-market cycle that compresses MGA growth rates and pressures fronting carrier underwriting margins. A move back to positive would reset multiple bands at the upper end. (Confidence: HIGH on the importance of the next outlook revision.)
2. Whether public specialty insurers (BOW, SKWD, ARX, HGTY) hold their multiples through soft-market rate decline. The public-market specialty insurance comp set sets the floor for private-market MGA exit multiples. If BOW, SKWD, and ARX hold their current revenue growth trajectories through Q1-Q2 2027, the public market will continue to anchor MGA exit pricing at 14-18x EBITDA for the top of the band. If any of the three lose more than 30% of market capitalization in the next 12 months, sponsors should mark down their private-market MGA exit assumptions accordingly. (Confidence: HIGH.)
3. Whether the Top Four strategic acquirers (MMC, AON, AJG, BRO) absorb additional large specialty platforms or pause for integration. The $46B absorbed across the November 2024 to January 2026 window leaves significant integration overhead at each of the Top Four. Sponsors holding $5B+ EV specialty platforms for exit in 2026-2027 should track integration milestones at MMC / McGriff, AJG / AssuredPartners, and Brown & Brown / Accession before assuming the Top Four will return as buyers at scale. (Confidence: MEDIUM on integration timing; HIGH on the importance of the marker.)
4. Whether cyber MGA consolidation produces 1-2 mega-deals. The Coalition / Resilience / At-Bay survivor outcome is the most-watched cyber consolidation question. A $1B+ acquisition of any of the three by a major strategic (Travelers’ Corvus playbook, Munich Re, Hartford, or Chubb) would signal the cyber MGA consolidation phase has accelerated. Absence of such a deal through year-end 2027 would suggest cyber MGA consolidation will run multi-cycle rather than peak-and-trough. (Confidence: MEDIUM on the outcome; HIGH on the importance of the marker.)
5. Whether NAIC issues sharper fronting-carrier governance rules. The Florida OIR Accredited examination is the canonical state-level example, but state-by-state supervisory letters without NAIC-level model act updates create operational uncertainty for fronting carriers. A NAIC-level fronting carrier governance update through 2026-2027 would compress multiple bands at the low end of the fronting carrier valuation band but would also reduce execution risk on new program manager launches. (Confidence: MEDIUM on the timing; HIGH on the importance.)
6. Whether Hagerty’s Markel-fronted 100% premium control model (effective January 1, 2026) gets replicated by other consumer MGA platforms. The Hagerty / CNIC / Markel structure is the cleanest “MGA roll-up to MGU roll-up with hybrid paper” precedent. If other consumer MGAs (specialty pet, marine, classic auto adjacents) follow the Hagerty playbook through 2026-2027, the structural shift from MGA-dependence to controlled-paper economics will accelerate. (Confidence: MEDIUM on replication speed; HIGH on the directional shift.)

23. Limitations and Gap Disclosures

The following items carry meaningful uncertainty or could not be verified in primary public sources within the time window of this brief:

1. US Risk Insurance Group sponsor identity. Original brief asked for sponsor; current public coverage did not surface a clear PE owner. GAP.
2. Programs Risk Solutions. No clean primary source found in this research pass. GAP.
3. StarStone Specialty / Enstar relationship post-2024: Enstar itself went through significant restructuring in 2024; specific StarStone subsidiary structure not verified within this pass. GAP.
4. AmTrust Financial Services ownership structure detail beyond Stone Point + Trian + Karfunkel family: not verified to current cap table in this research. GAP.
5. Generali Global Assistance specific MGA premium volume: not surfaced. GAP.
6. Vouch Insurance valuation and capital stack 2024-2026: not surfaced. GAP.
7. Verikai and Counterpart Cyber 2024-2026 cap-table updates: not surfaced. GAP.
8. Cottingham & Butler Specialty sponsor: not surfaced; private broker, family-owned. CONFIDENCE: LOW that PE involvement exists.
9. Coverys medical malpractice MGA sponsor: not surfaced in this pass. GAP.
10. Cowbell post-Series C valuation: not publicly disclosed as of this brief. GAP.
11. Coalition Allianz transition specifics (May 2026 standalone-cyber-book transfer): directional source confirms; specific premium / EV figures not surfaced. GAP.
12. Vantage Risk Group exact sponsor mix percentages: Carlyle and Hellman & Friedman confirmed elsewhere but specific ownership splits not surfaced in this pass. GAP.
13. Bowhead Specialty pre-IPO sponsor (American Financial Group via Great American) was the cornerstone capital but post-IPO secondary sales not tracked. GAP.
14. Greenlight Re post-2022 fronting and Lloyd’s Syndicate 3456 capacity growth: research pass surfaced primarily 2022 announcements; 2024-2026 underwriting volume not verified. GAP.
15. Convex Insurance US exposure quantification: UK-based; US exposure detail not verified in this pass. GAP.
16. IGI Holdings fronting capacity US: not surfaced. GAP.
17. Lemonade NYSE: LMND MGU operations breakout vs direct underwriting: not analyzed in detail in this pass. GAP.

(Confidence: HIGH on the gap disclosure itself; the gaps are stated explicitly so readers can adjust their thesis weights accordingly.)

24. Related CT Research

• Who Buys Insurance Agencies in 2026: the retail-broker sister piece to this specialty / wholesale / MGA / fronting carrier deep-dive.
• Sell My Insurance Agency: the seller-fit and transaction-structure primer for agency owners considering exit.
• Insurance Agency Valuation 2026: the EV / EBITDA, revenue, and recurring-commission valuation framework.
• Best Reps and Warranties Insurance Brokers: the deal-mechanics piece on R&W placement, which intersects with MGA-fronted policies in middle-market private equity transactions.
• CT Platform Map: the master tracker of active PE platforms across the categories CT Acquisitions follows.
• Continuation Vehicles in Private Equity 2026: the CV-fund structure piece relevant to sponsor exit timing on specialty insurance platforms held longer than fund-life.
• Independent Sponsor Private Equity 2026: the deal-by-deal sponsor model used by some specialty insurance acquirers.
• Family Office Private Equity 2026: the long-dated capital pool that increasingly partners with specialty insurance platforms.
• Search Fund Private Equity 2026: the operator-led acquisition model that occasionally touches small specialty broker and MGA targets.

25. Sources

1. AM Best, “E&S in 2024: Premium Grows to $135B” via Insurance Insider US (September 2025). Link
2. WSIA Stamping Office Composite via The Insurer, “Stamping Office Surplus Lines Premium Up 8% in 2025 to $90.3 Billion” (January 30 2026). Link
3. Risk & Insurance, “Surplus Lines Premiums Surge to $46.2 Billion in First Half of 2025.” Link
4. AM Best E&S Outlook Revision via Carrier Management (November 26 2025). Link
5. Conning 2025 MGA Strategic Study via PR Newswire, “US MGA Premiums Climb 16% to $114 Billion in 2024.” Link
6. Patra via Conning, “What’s Behind the Excess & Surplus Line Growth Surge.” Link
7. Carrier Management, “MGA Premium 2024 Breakdown” (July 9 2025). Link
8. Genstar Capital, “Amwins Completes $1.0 Billion Recapitalization Transaction” (November 15 2023). Link
9. Ryan Specialty news releases, including USQRisk Holdings definitive agreement. Link
10. Motley Fool, “Ryan Specialty (RYAN) Q1 2026 Earnings Transcript” (May 1 2026). Link
11. H.W. Kaufman Group press release on Burns & Wilcox / RB Jones consolidation. Link
12. Mubadala 2024 Annual Report, Truist Insurance Holdings transformational journey. Link
13. McGriff release on Marsh McLennan acquisition closing. Link
14. Insurance Journal, “Brown & Brown / Accession Risk Management” (June 10 2025). Link
15. Risk Strategies release on Brown & Brown acquisition completion. Link
16. GTCR release on AssuredPartners sale to Arthur J. Gallagher. Link
17. Arthur J. Gallagher Investor Relations release on AssuredPartners closing. Link
18. Hub International press release on May 2025 minority equity investment. Link
19. Business Insurance, “Hub Wholesale Unit Reorganizes Operations.” Link
20. Carlyle portfolio of investments, Hilb Group. Link
21. Carlyle release on White Mountains / NSM Insurance Group sale. Link
22. White Mountains Investor Relations on Distinguished Programs majority stake. Link
23. Carlyle release on Trucordia $1.3B strategic investment. Link
24. Acrisure release on Bain Capital $2.1B preferred investment. Link
25. Hagerty Q3 2025 press release via SEC EDGAR. Link
26. Hagerty Q4 2024 press release via SEC EDGAR. Link
27. Hagerty Q2 2025 press release via SEC EDGAR. Link
28. Sentry release on Falvey Insurance partnership. Link
29. Skyward Specialty FY2025 financial summary via Stock Analysis. Link
30. Skyward Specialty / Westaim exit via SimplyWall.st. Link
31. Bowhead Specialty FY2024 release via SEC EDGAR. Link
32. Bowhead Specialty 2025 financial summary via Stock Analysis. Link
33. Bharcap Partners portfolio page (Clear Blue Insurance Group). Link
34. The Insurer, “Clear Blue Adds Duo to Support Continued Growth of Repositioned Portfolio.” Link
35. Trisura Group Q2 2024 results. Link
36. Trisura Group Q3 2024 results. Link
37. Insurance Journal on Onex / Accredited Insurance acquisition. Link
38. Florida OIR Accredited Surety financial examination. Link
39. Reinsurance News on Vantage S&P rating. Link
40. Benzinga on Greenlight Re Syndicate 3456 launch. Link
41. The Insurer on Spinnaker $1B GWP run rate. Link
42. Baldwin Group Investor Relations on Hippo homebuilder distribution acquisition. Link
43. AInvest on Accelerant Holdings IPO blueprint. Link
44. The Insurer on Accelerant Lloyd’s syndicate business plan. Link
45. WTW Investor Relations on Newfront acquisition completion. Link
46. Coalition release on Series F closing. Link
47. Insurance Journal on Allianz / Coalition cyber book transition. Link
48. The Insurer interview with Coalition CEO on cyber consolidation. Link
49. PR Newswire on Cowbell Series C from Zurich. Link
50. Resilience on Lloyd’s facility limit doubling. Link
51. PitchBook Resilience profile. Link
52. PR Newswire on Pie Insurance 2025 reporting. Link
53. SeedPod Cyber on Travelers / Corvus integration. Link
54. Insurance Journal on AssuredPartners closing (August 18 2025). Link
55. The Insurer on Brown & Brown / Accession completion. Link
56. Insurance Journal on McGriff closing (November 18 2024). Link
57. Brown & Brown IR on Accession acquisition completion. Link
58. Sica Fletcher 2025 Valuations, Interest Rates, Spreads, Deal Volume. Link
59. William Blair Insurance Distribution 2025 research. Link
60. SpeedBuilder Systems on MGA valuation drivers. Link
61. Insurnest blog on NAIC MGA Model Act. Link
62. 2025 Excess & Surplus Lines Laws Manual. Link
63. Artemis on Florida insurance carriers mid-year 2025 reinsurance renewals. Link
64. Jencap Group on the state of the E&S property market. Link
65. KBRA via Financial Content on fronting market changes post-Vesttoo. Link
66. Risk & Insurance on MGA market surge to $100B and fronting carrier composite. Link
67. Sonant on insurance broker salary trends. Link
68. Sonant on insurance agent commission structure. Link
69. MarshBerry on commission split for drive motivation and growth. Link

26. Frequently Asked Questions

Who owns AmWINS Group as of 2026?

AmWINS Group’s cap table is led by Dragoneer Investment Group, with Genstar Capital, SkyKnight Capital, and PSP Investments alongside an approximately 40% employee shareholder block. Stone Point Capital is NOT in the AmWINS cap table; it sits at CRC / Truist Insurance Holdings instead. The recapitalization closed November 15, 2023 for $1.0B in equity per the Genstar press release.

Who owns Clear Blue Insurance Group?

Clear Blue Insurance Group is owned by Bharcap Partners per the Bharcap portfolio page. Coverage that places Clear Blue under Brookfield Reinsurance is incorrect.

What was the US E&S premium in 2024?

Approximately $135 billion per AM Best’s September 2025 market segment report, up 12.3% from 2023. The 15-state WSIA stamping office composite measured $90.3 billion in FY2025, up 7.8% year on year with policy item counts up 14.1%.

What was the US MGA premium in 2024?

$114.1 billion per Conning’s 2025 MGA Strategic Study, up 16% year on year, with 46.6% from non-affiliated MGAs, 45.3% from affiliated MGAs, and 8.1% from crop MGAs.

What was the fronting carrier GWP in 2024?

$28 billion per the Gallagher Re composite of 23 leading fronts, up 26% year on year, supporting roughly 20% of total US MGA premium. Four fronting carriers each wrote more than $1B in 2024: Accelerant, Sutton, Transverse, and State National.

What was the Coalition valuation in October 2024?

$5 billion, reaffirming the cyber MGA unicorn status. Coalition’s Series F closed in June 2025 with a $30M follow-on March 3, 2025. Cumulative funding exceeded $800M over seven rounds.

What was the Accelerant Holdings IPO valuation?

$6.4 billion at the Day 1 close on July 24-25, 2025. The IPO priced at $21/share (upsized, $1 above range) and raised approximately $724M. The stock debuted 35% above IPO price.

Which deals reshaped US specialty broker M&A in 2024 to 2026?

Four headline deals: Gallagher / AssuredPartners $13.45B (August 18 2025); Brown & Brown / Accession $9.825B (August 1 2025); MMC / McGriff $7.75B (November 15 2024); and Truist / Mubadala + Stone Point + CD&R $15.5B EV (2024). Combined with WTW / Newfront $1.3B (January 27 2026), the “Top Four” strategic acquirers absorbed approximately $46 billion of specialty / middle-market broker EV across the 14-month window.

What are the EV / EBITDA multiples for US specialty brokers in mid-2026?

H1 2025 specialty broker EBITDA averaged 11.8x per Sica Fletcher across deals with at least $1.0M EBITDA. Public specialty brokers (MMC, Aon, AJG) trade at 16-18x. Large platform M&A clears at 11-14x EBITDAC; tuck-ins at 7.5-12x. MGA range is 9-18x EBITDA with MGUs at the upper end. Fronting carriers cluster at 8-13x EBITDA / 9-10x revenue post-Vesttoo.

Which sponsor has the largest US specialty insurance concentration?

Carlyle, with four meaningful US specialty / brokerage / MGA platforms: NSM Insurance Group (since 2022), The Hilb Group (since 2019), Trucordia (Carlyle Global Credit $1.3B at $5.7B EV June 2025), and Vantage Risk Group (co-sponsor with Hellman & Friedman).

27. FAQ Schema

Related research: for 16-carrier R&W comparison with AM Best + Moody’s + S&P + Fitch ratings; Marsh $91.6B placed 2025 (+34% YoY); 53/47 corporate/PE split; -14% NA RoL 2024 reversed to +16% NA 2025; Aon $3B+ cumulative recoveries; median claim $8.2M 2025 vs $5.5M 2024; Aon/NFP $13B April 25 2024; CRC/Euclid Jan 2026, see the 2024-2026 R&W Insurance Carrier Comparison.

Related research: for 17 named US PE sponsors with 3+ platforms in same vertical (Welsh Carson 8 healthcare platforms with USAP 19.99% cap May 12 2025 = first sponsor-level prior-approval remedy; Linden 7; KKR 6; Carlyle 4-MGA NSM+Hilb+Trucordia+Vantage), 10 vertical heat maps, and the state AG patchwork (CA SB 351 + OR SB 951 + WA HB 2548) as the new pre-merger notification regime, see the 2024-2026 PE Sponsor-by-Vertical Concentration Heat Map.

Related research: for Cerulli updated $124T Great Wealth Transfer through 2048, UBS 91 heirs / $297.8B 2025, OBBBA July 4 2025 $15M estate exemption permanent, Murdoch Sept 8 2025 $3.3B settlement = Succession TV template, Tata Noel Oct 11 2024, Samsung 12T won May 2026 inheritance tax completion, Chey Tae-won Oct 16 2025 Supreme Court reversal, see the 2024-2026 Family Office Succession + Generational Wealth Transfer Tracker.

Related research: for $115B GP-led 2025 volume, 28 named CV transactions, Vista/Cloud Software $5.6B, 5th Circuit PFAR vacatur, see the 2026 US GP-Led Continuation Vehicle Market Report.

28. About the Author

This report was produced by CT Acquisitions, a private equity research and execution firm focused on specialty insurance, retail brokerage, MGA, MGU, and fronting carrier transactions in the US middle market. CT Acquisitions tracks 31+ active PE platform categories across specialty insurance and adjacent services. For sponsor identification, multiple bands, and seller-fit analysis, contact CT Acquisitions directly through the platform map at ctacquisitions.com/platform-map.

Last updated: June 21, 2026.